-
Importance of Research
It’s a new year of groundbreaking research for the FA Community! Here are key highlights on Friedreich’s Ataxia Research Alliance (FARA) Research Pipeline:-The GeneTAC clinical trial to start in the first half of this year
-AavantiBio’s gene therapy trial to start by the end of the year -Reata’s
-Omaveloxolone will be going up for FDA approval the first quarter of this yearNone of this would be possible without participation from FA patients. The faster we enroll in clinical studies and trials, the faster they find a treatment and/or cure.
Log in to reply.